| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Financial Officer | Chief Financial Officer
1 company
McGrath John is an EVP &Chief Financial Officer at Atara Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $936K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2016 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 5,000 | $17.47 | $87,325.00 | -2.5% | |
| May 16, 2016 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sale+OE | 5,395 | $15.77 | $85,079.15 | -5.7% | |
| Feb 16, 2016 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sale+OE | 6,000 | $15.49 | $92,940.00 | -6.7% | |
| Nov 30, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 6,000 | $40.00 | $240,000.00 | -14.2% | |
| Aug 18, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sale+OE | 6,000 | $49.38 | $296,280.00 | -15.9% | |
| Jun 15, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 10,000 | $50.00 | $500,000.00 | -26.8% | |
| May 29, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 10,000 | $40.00 | $400,000.00 | -21.1% |